Cell Lysis Composition Merging Nucleic Acid Extraction and PCR

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Conventional molecular diagnostic methods require a separate nucleic acid extraction process, which is time-consuming and costly, especially in emergency situations and for rapid virus quarantine, due to the need for dedicated devices and consumables.

Innovation Solution

A molecular diagnostic method using a cell lysis composition containing Tween 20 and distilled water, which allows for simultaneous nucleic acid extraction and amplification during the polymerase chain reaction without a separate extraction process, by preparing a mixture with the cell lysis composition, a nucleic acid-containing sample, a premix, and a solution containing primers and a probe.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If a separate nucleic acid extraction process is performed using conventional methods, then high purity nucleic acid can be extracted, but the extraction process requires a long period (about 60 minutes) and dedicated extraction devices and consumables

Engineering Contradiction:
Improvenucleic acid purityVSAvoidextraction time
Core Design Contradiction:
Manufacturing precisionVSLoss of time

Solution Approach 1:

The patent combines the nucleic acid extraction process with the PCR amplification process into a single unified reaction system. The cell lysis composition containing Tween 20 serves dual purposes: it extracts nucleic acids from cells and simultaneously provides the reaction environment for PCR amplification, eliminating the need for separate extraction and amplification steps

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The cell lysis composition is designed to perform multiple functions: cell membrane disruption, nucleic acid release, and serving as a buffer for PCR reaction. This multi-functional composition eliminates the need for dedicated extraction devices and consumables, as the same reagents are used for both extraction and amplification

Inventive Principle:
Principle #6Universality (Multi-functionality)

2Manufacturing precision

If conventional extraction methods are used, then nucleic acid can be extracted with high purity, but dedicated extraction devices and consumables must be continuously used, incurring high costs

Engineering Contradiction:
Improvenucleic acid purityVSAvoiddiagnosis cost
Core Design Contradiction:
Manufacturing precisionVSEase of manufacture

Solution Approach 1:

The patent merges extraction reagents with PCR reagents into a single cell lysis composition, eliminating the need for separate extraction kits, magnetic beads, and dedicated extraction devices. This consolidation significantly reduces consumable costs and simplifies the diagnostic workflow

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The cell lysis composition serves multiple purposes including cell lysis, nucleic acid extraction, and PCR reaction buffer, replacing multiple dedicated extraction consumables with a single multi-functional reagent system that reduces overall diagnostic costs

Inventive Principle:
Principle #6Universality (Multi-functionality)

3Quantity of substance

If a separate nucleic acid extraction process is performed, then adequate nucleic acid can be obtained for PCR, but the overall molecular diagnosis time is extended

Engineering Contradiction:
Improvenucleic acid amountVSAvoiddiagnosis speed
Core Design Contradiction:
Quantity of substanceVSProductivity

Solution Approach 1:

The patent combines extraction and amplification into a single simultaneous process where the cell lysis composition extracts nucleic acids while the PCR reaction amplifies them in the same reaction vessel and time frame, achieving both adequate nucleic acid quantity and rapid diagnosis

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The cell lysis composition is pre-formulated to contain all necessary components for both extraction and PCR reaction, including buffers, enzymes, and primers, allowing the extraction and amplification to proceed simultaneously without sequential processing delays

Inventive Principle:
Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method reduces the time and cost of molecular diagnosis by eliminating the need for dedicated extraction devices and consumables, while achieving effective nucleic acid extraction and amplification.

Implementation Method 1

a cell lysis composition for nucleic acid extraction containing Tween 20 and distilled water

Methodology Applied
Scientific EffectSurfactant: Surfactant

Data Source

PatentEP4019644A1Molecular diagnostic method using cell lysis composition for nucleic acid extraction
Publication Date: 2022.06.29 INVITROS CO LTD
  • EP4019644A1 patent drawingFigure 1
  • EP4019644A1 patent drawingFigure 2~3
  • EP4019644A1 patent drawing

AI summary

The present invention relates to a molecular diagnostic method using a cell lysis composition for nucleic acid extraction, and particularly, to a molecular diagnostic method using a cell lysis composition for nucleic acid extraction, which may minimize the time for molecular diagnosis by performing a polymerase chain reaction on a mixture containing both Tween 20 as a component for nucleic acid extraction and a PCR buffer necessary for performing the polymerase chain reaction, without a separate nucleic acid extraction process, and reduce the cost of molecular diagnosis by minimizing the use of dedicated devices and consumables in extraction.